Serum squalene in postmenopausal women without and with coronary artery disease

Atherosclerosis. 1999 Sep;146(1):61-4. doi: 10.1016/s0021-9150(99)00129-x.

Abstract

Squalene, found in earlier studies in human atherosclerotic plaques, was measured in the serum of postmenopausal women with coronary artery disease (CAD) (n = 25) and randomly chosen age-matched healthy controls (n = 30). The squalene concentrations of the whole population ranged from 37.5 to 115.5 microg/dl, and were higher in serum of the CAD than healthy women (91.4+/-2.6 versus 65.2+/-2.6 microg/dl, P = 0.000), a finding observed also in relation to cholesterol (43.8+/-1.8 versus 32.9+/-1.1 10(2)x mmol/mol of cholesterol, P = 0.000). The squalene concentration was also increased in chylomicrons, VLDL and d>1.006 g/ml lipoproteins, and the proportions to cholesterol in VLDL and d>1.006 g/ml lipoproteins. The respective squalene and cholesterol concentrations were related to each other in serum, VLDL and d>1.006 g/ml lipoproteins (r = 0.52, 0.85 and 0.55, respectively), whereas the correlation with triglycerides was seen only in VLDL (r = 0.84) over the whole population. Besides enhanced intestinal secretion, it remains to be shown whether higher serum squalene in postmenopausal coronary women is due to increased cholesterol synthesis or a defect in squalene conversion to lanosterol.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Cholesterol / blood
  • Coronary Disease / blood*
  • Female
  • Humans
  • Linear Models
  • Lipoproteins, VLDL / blood
  • Middle Aged
  • Postmenopause / blood*
  • Reference Values
  • Sensitivity and Specificity
  • Squalene / analysis
  • Squalene / blood*
  • Statistics, Nonparametric

Substances

  • Biomarkers
  • Lipoproteins, VLDL
  • Squalene
  • Cholesterol